Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,300 warrant series at 1,050 companies. 779 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 3 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| February 2025 Common Warrants – unamended investor tranche ($1.50) | $0.8938 | $102.7M | 10-K, Mar 30, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| JGB Warrants (April 2025 debenture financing) | $0.8938 | $102.7M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2025 Common Warrants | $0.8938 | $102.7M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Pre-Funded Warrants issued Nov 9, 2026 on Nant Common Warrant exercise | $0.8938 | $102.7M | SCHEDULE 13D/A, Nov 12, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| September 2026 Common Warrants – AB Group Ltd. | $0.8938 | $102.7M | S-3, Oct 14, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| September 2026 Common Warrants – NIS Holdings LLC | $0.8938 | $102.7M | S-3, Oct 14, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| September 2026 Pre-Funded Warrants (Initial Closing) | $0.8938 | $102.7M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| YA II PN Warrant (April 2026 SPA) | $0.8938 | $102.7M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| April 2024 Unit Offering Warrants ($3.65, expiring April 2, 2028) | $0.7069 | $102.2M | 6-K EX-99.1, Aug 11, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2025 Private Placement pre-funded warrants (Initial Closing) | $1.21 | $99.6M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2025 Private Placement pre-funded warrants (Milestone Closing) | $1.21 | $99.6M | 8-K, Oct 26, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| March 2026 Private Placement pre-funded warrant | $1.21 | $99.6M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Oxford Finance LLC warrant (September 30, 2019 loan warrant) | $1.21 | $99.6M | 10-Q EX-4.2, Nov 12, 2019Dilution tabAs of Nov 13, 2026 | ||||||||
| Silicon Valley Bank warrant (September 30, 2019 loan warrant) | $1.21 | $99.6M | 10-Q EX-4.3, Nov 12, 2019Dilution tabAs of Nov 13, 2026 | ||||||||
| Innoviva Sub warrants – 1,807,396 shares at $5.00 (expiring January 26, 2031) | $2.66 | $98.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Innoviva Sub warrants – 1,867,912 shares at $3.25 (expiring January 26, 2031) | $2.66 | $98.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Innoviva Sub warrants – 2,692,604 shares at $5.00 (expiring January 26, 2031) | $2.66 | $98.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Innoviva Sub warrants – 4,285,935 shares at $3.25 (expiring January 26, 2031) | $2.66 | $98.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Legacy warrants – 1,200 shares at $1,680.00 (no expiration) | $2.66 | $98.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series G warrants (converted to common stock warrants at IPO) | $8.88 | $98.5M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2023 Pre-Funded Warrants (April 2023 Private Placement) | $1.03 | $98.3M | 10-K, Mar 19, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2024 Pre-Funded Warrants (April 2024 Private Placement) | $1.03 | $98.3M | 10-K, Mar 19, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2024 Share Exchange Warrants (August 2024) | $1.03 | $98.3M | 10-K, Mar 19, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2025 Share Exchange Warrants (April 2025) | $1.03 | $98.3M | 10-K, Mar 19, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| February 2026 Pre-Funded Warrants (February 2026 Equity Offering) | $1.03 | $98.3M | 10-Q, Oct 27, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series A Warrants | $3.25 | $97.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| SVB Warrants | $3.25 | $97.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Titan Warrants (underwriter warrant, September 2024 offering) | $3.25 | $97.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| PubCo Warrants – Closing PIPE (Alyeska Master Fund, L.P.) | $2.52 | $96.5M | 20FR12B, Oct 1, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| PubCo Warrants – Signing PIPE (Inflection Point Fund I, LP) | $2.52 | $96.5M | 20FR12B, Oct 1, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| 2025 Warrants (June 2025 convertible note financing, $0.04) | $0.4950 | $96.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2026 placement agent warrants ($0.4391) | $0.4950 | $96.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2026 Warrants (Series D investor warrants, $0.4391) | $0.4950 | $96.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| August 2025 financing activity warrants ($0.04, 24-month vesting) | $0.4950 | $96.2M | 10-K, Mar 31, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| December 2025 financing activity warrants ($0.04) | $0.4950 | $96.2M | 10-K, Mar 31, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2025 financing activity warrants ($0.115) | $0.4950 | $96.2M | 10-K, Mar 31, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Private Placement Warrants (AAC Sponsor) | $0.4950 | $96.2M | 10-K, Mar 31, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Public Warrants (AAC IPO) | $0.4950 | $96.2M | S-1/A, Jul 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Perceptive Warrant Certificate – Tranche B Warrant Shares (vested Nov 9, 2026) | $3.76 | $95.9M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| February 2025 Registered Direct Offering Placement Agent Warrants | $6.97 | $95.8M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2025 PIPE Placement Agent Warrants (H.C. Wainwright designees) | $6.97 | $95.8M | 424B3, Nov 24, 2025Dilution tabAs of Nov 17, 2026 | ||||||||
| Pre-funded warrants (Cash PIPE and Crypto PIPE, combined remaining) | $6.97 | $95.8M | 10-Q, Nov 17, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Strategic Advisor Warrants (DNA Holdings Venture, Inc.) | $6.97 | $95.8M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Warrants granted in 2021 - per 10-K year-of-grant table | $6.97 | $95.8M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Warrants granted in 2022 - per 10-K year-of-grant table | $6.97 | $95.8M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Warrants granted in 2024 (July 2024 Series A, Series B and inducement placement agent warrants) - per 10-K year-of-grant table | $6.97 | $95.8M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Executive Chairman Warrant (Credit Facility pledge consideration), $5.00, issued July 22, 2026 | $2.25 | $95.5M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Advisory Warrant to Purchase Common Shares issued to David Joshua Bartch (March 23, 2026) | $1.71 | $95.2M | F-1, Sep 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| March 2024 Registered Direct Common Warrants ($3.80, Sabby) | $1.05 | $94.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| NPM unit warrants ($3.15, issued 2019-2021) | $1.05 | $94.8M | 424B5, Sep 25, 2026Dilution tabAs of Nov 16, 2026 |
PDSBPDS Biotechnology Corporation$0.8938Last price
February 2025 Common Warrants – unamended investor tranche ($1.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.7M
PDSBPDS Biotechnology Corporation$0.8938Last price
JGB Warrants (April 2025 debenture financing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.7M
PDSBPDS Biotechnology Corporation$0.8938Last price
November 2025 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.7M
PDSBPDS Biotechnology Corporation$0.8938Last price
Pre-Funded Warrants issued Nov 9, 2026 on Nant Common Warrant exercise
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.7M
PDSBPDS Biotechnology Corporation$0.8938Last price
September 2026 Common Warrants – AB Group Ltd.
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.7M
PDSBPDS Biotechnology Corporation$0.8938Last price
September 2026 Common Warrants – NIS Holdings LLC
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.7M
PDSBPDS Biotechnology Corporation$0.8938Last price
September 2026 Pre-Funded Warrants (Initial Closing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.7M
PDSBPDS Biotechnology Corporation$0.8938Last price
YA II PN Warrant (April 2026 SPA)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.7M
OGIOrganigram Global Inc.$0.7069Last price
April 2024 Unit Offering Warrants ($3.65, expiring April 2, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$102.2M
EQEquillium, Inc.$1.21Last price
August 2025 Private Placement pre-funded warrants (Initial Closing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$99.6M
EQEquillium, Inc.$1.21Last price
August 2025 Private Placement pre-funded warrants (Milestone Closing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$99.6M
EQEquillium, Inc.$1.21Last price
March 2026 Private Placement pre-funded warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$99.6M
EQEquillium, Inc.$1.21Last price
Oxford Finance LLC warrant (September 30, 2019 loan warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$99.6M
EQEquillium, Inc.$1.21Last price
Silicon Valley Bank warrant (September 30, 2019 loan warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$99.6M
ARMPArmata Pharmaceuticals, Inc.$2.66Last price
Innoviva Sub warrants – 1,807,396 shares at $5.00 (expiring January 26, 2031)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.9M
ARMPArmata Pharmaceuticals, Inc.$2.66Last price
Innoviva Sub warrants – 1,867,912 shares at $3.25 (expiring January 26, 2031)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.9M
ARMPArmata Pharmaceuticals, Inc.$2.66Last price
Innoviva Sub warrants – 2,692,604 shares at $5.00 (expiring January 26, 2031)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.9M
ARMPArmata Pharmaceuticals, Inc.$2.66Last price
Innoviva Sub warrants – 4,285,935 shares at $3.25 (expiring January 26, 2031)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.9M
ARMPArmata Pharmaceuticals, Inc.$2.66Last price
Legacy warrants – 1,200 shares at $1,680.00 (no expiration)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.9M
BDSXBiodesix, Inc.$8.88Last price
Series G warrants (converted to common stock warrants at IPO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.5M
ZURAZura Bio Limited$1.03Last price
2023 Pre-Funded Warrants (April 2023 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.3M
ZURAZura Bio Limited$1.03Last price
2024 Pre-Funded Warrants (April 2024 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.3M
ZURAZura Bio Limited$1.03Last price
2024 Share Exchange Warrants (August 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.3M
ZURAZura Bio Limited$1.03Last price
2025 Share Exchange Warrants (April 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.3M
ZURAZura Bio Limited$1.03Last price
February 2026 Pre-Funded Warrants (February 2026 Equity Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$98.3M
OWLTOwlet, Inc.$3.25Last price
Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$97.1M
OWLTOwlet, Inc.$3.25Last price
SVB Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$97.1M
OWLTOwlet, Inc.$3.25Last price
Titan Warrants (underwriter warrant, September 2024 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$97.1M
GOWInflection Point Acquisition Corp.$2.52Last price
PubCo Warrants – Closing PIPE (Alyeska Master Fund, L.P.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.5M
GOWInflection Point Acquisition Corp.$2.52Last price
PubCo Warrants – Signing PIPE (Inflection Point Fund I, LP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.5M
ZPTAZapata Quantum, Inc.$0.4950Last price
2025 Warrants (June 2025 convertible note financing, $0.04)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.2M
ZPTAZapata Quantum, Inc.$0.4950Last price
2026 placement agent warrants ($0.4391)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.2M
ZPTAZapata Quantum, Inc.$0.4950Last price
2026 Warrants (Series D investor warrants, $0.4391)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.2M
ZPTAZapata Quantum, Inc.$0.4950Last price
August 2025 financing activity warrants ($0.04, 24-month vesting)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.2M
ZPTAZapata Quantum, Inc.$0.4950Last price
December 2025 financing activity warrants ($0.04)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.2M
ZPTAZapata Quantum, Inc.$0.4950Last price
March 2025 financing activity warrants ($0.115)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.2M
ZPTAZapata Quantum, Inc.$0.4950Last price
Private Placement Warrants (AAC Sponsor)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.2M
ZPTAZapata Quantum, Inc.$0.4950Last price
Public Warrants (AAC IPO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$96.2M
XGNExagen Inc.$3.76Last price
Perceptive Warrant Certificate – Tranche B Warrant Shares (vested Nov 9, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.9M
AGPUAxe Compute Inc.$6.97Last price
February 2025 Registered Direct Offering Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.8M
AGPUAxe Compute Inc.$6.97Last price
October 2025 PIPE Placement Agent Warrants (H.C. Wainwright designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.8M
AGPUAxe Compute Inc.$6.97Last price
Pre-funded warrants (Cash PIPE and Crypto PIPE, combined remaining)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.8M
AGPUAxe Compute Inc.$6.97Last price
Strategic Advisor Warrants (DNA Holdings Venture, Inc.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.8M
AGPUAxe Compute Inc.$6.97Last price
Warrants granted in 2021 - per 10-K year-of-grant table
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.8M
AGPUAxe Compute Inc.$6.97Last price
Warrants granted in 2022 - per 10-K year-of-grant table
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.8M
AGPUAxe Compute Inc.$6.97Last price
Warrants granted in 2024 (July 2024 Series A, Series B and inducement placement agent warrants) - per 10-K year-of-grant table
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.8M
CCLDCareCloud, Inc.$2.25Last price
Executive Chairman Warrant (Credit Facility pledge consideration), $5.00, issued July 22, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.5M
RZAIRoze AI Inc.$1.71Last price
Advisory Warrant to Purchase Common Shares issued to David Joshua Bartch (March 23, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$95.2M
VANIVivani Medical, Inc.$1.05Last price
March 2024 Registered Direct Common Warrants ($3.80, Sabby)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$94.8M
VANIVivani Medical, Inc.$1.05Last price
NPM unit warrants ($3.15, issued 2019-2021)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$94.8M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,061 dilution snapshots. 4,846 of 5,300 series state an exercise price and 3,366 an expiry date. 98 record when exercise begins; that count grows as companies are re-extracted. 633 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.